vs
Healthpeak Properties（DOC）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Healthpeak Properties的1.9倍（$1.4B vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 3.4%，领先69.8%），Healthpeak Properties同比增速更快（3.1% vs 1.3%），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 4.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
DOC vs OPCH — 直观对比
营收规模更大
OPCH
是对方的1.9倍
$719.4M
营收增速更快
DOC
高出1.7%
1.3%
净利率更高
DOC
高出69.8%
3.4%
两年增速更快
DOC
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $1.4B |
| 净利润 | $114.0M | $45.3M |
| 毛利率 | — | 19.4% |
| 营业利润率 | 17.4% | 5.4% |
| 净利率 | 73.2% | 3.4% |
| 营收同比 | 3.1% | 1.3% |
| 净利润同比 | 2406.4% | -3.0% |
| 每股收益（稀释后） | $0.16 | $0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCOPCH
| Q1 26 | — | $1.4B | ||
| Q4 25 | $719.4M | $1.5B | ||
| Q3 25 | $705.9M | $1.4B | ||
| Q2 25 | $694.3M | $1.4B | ||
| Q1 25 | $702.9M | $1.3B | ||
| Q4 24 | $698.0M | $1.3B | ||
| Q3 24 | $700.4M | $1.3B | ||
| Q2 24 | $695.5M | $1.2B |
净利润DOCOPCH
| Q1 26 | — | $45.3M | ||
| Q4 25 | $114.0M | $58.5M | ||
| Q3 25 | $-117.1M | $51.8M | ||
| Q2 25 | $31.7M | $50.5M | ||
| Q1 25 | $42.8M | $46.7M | ||
| Q4 24 | $4.5M | $60.1M | ||
| Q3 24 | $85.9M | $53.9M | ||
| Q2 24 | $146.0M | $53.0M |
毛利率DOCOPCH
| Q1 26 | — | 19.4% | ||
| Q4 25 | — | 19.3% | ||
| Q3 25 | 58.6% | 19.0% | ||
| Q2 25 | 60.2% | 19.0% | ||
| Q1 25 | 61.1% | 19.7% | ||
| Q4 24 | 60.3% | 21.3% | ||
| Q3 24 | 60.0% | 20.1% | ||
| Q2 24 | 60.6% | 20.3% |
营业利润率DOCOPCH
| Q1 26 | — | 5.4% | ||
| Q4 25 | 17.4% | 6.2% | ||
| Q3 25 | 9.2% | 5.9% | ||
| Q2 25 | 5.7% | 5.8% | ||
| Q1 25 | 7.7% | 5.9% | ||
| Q4 24 | -2.2% | 6.9% | ||
| Q3 24 | 14.1% | 6.7% | ||
| Q2 24 | 22.3% | 6.6% |
净利率DOCOPCH
| Q1 26 | — | 3.4% | ||
| Q4 25 | 73.2% | 4.0% | ||
| Q3 25 | -16.6% | 3.6% | ||
| Q2 25 | 4.6% | 3.6% | ||
| Q1 25 | 6.1% | 3.5% | ||
| Q4 24 | 0.7% | 4.8% | ||
| Q3 24 | 12.3% | 4.2% | ||
| Q2 24 | 21.0% | 4.3% |
每股收益（稀释后）DOCOPCH
| Q1 26 | — | $0.29 | ||
| Q4 25 | $0.16 | $0.37 | ||
| Q3 25 | $-0.17 | $0.32 | ||
| Q2 25 | $0.05 | $0.31 | ||
| Q1 25 | $0.06 | $0.28 | ||
| Q4 24 | $0.02 | $0.36 | ||
| Q3 24 | $0.12 | $0.31 | ||
| Q2 24 | $0.21 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $177.3M |
| 总债务越低越好 | $9.8B | — |
| 股东权益账面价值 | $7.5B | — |
| 总资产 | $20.3B | $3.4B |
| 负债/权益比越低杠杆越低 | 1.31× | — |
8季度趋势，按日历期对齐
现金及短期投资DOCOPCH
| Q1 26 | — | $177.3M | ||
| Q4 25 | $467.5M | $232.6M | ||
| Q3 25 | $91.0M | $309.8M | ||
| Q2 25 | $89.4M | $198.8M | ||
| Q1 25 | $70.6M | $171.4M | ||
| Q4 24 | $119.8M | $412.6M | ||
| Q3 24 | $180.4M | $483.0M | ||
| Q2 24 | $106.9M | $376.9M |
总债务DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | — | ||
| Q3 25 | $9.1B | $1.2B | ||
| Q2 25 | $9.0B | $1.1B | ||
| Q1 25 | $8.9B | $1.1B | ||
| Q4 24 | $8.7B | $1.1B | ||
| Q3 24 | $8.6B | $1.1B | ||
| Q2 24 | $8.6B | $1.1B |
股东权益DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $1.3B | ||
| Q3 25 | $7.6B | $1.4B | ||
| Q2 25 | $7.9B | $1.4B | ||
| Q1 25 | $8.2B | $1.4B | ||
| Q4 24 | $8.4B | $1.4B | ||
| Q3 24 | $8.6B | $1.4B | ||
| Q2 24 | $8.8B | $1.4B |
总资产DOCOPCH
| Q1 26 | — | $3.4B | ||
| Q4 25 | $20.3B | $3.5B | ||
| Q3 25 | $19.6B | $3.5B | ||
| Q2 25 | $19.8B | $3.4B | ||
| Q1 25 | $19.8B | $3.3B | ||
| Q4 24 | $19.9B | $3.4B | ||
| Q3 24 | $20.0B | $3.4B | ||
| Q2 24 | $20.2B | $3.3B |
负债/权益比DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | — | ||
| Q3 25 | 1.20× | 0.86× | ||
| Q2 25 | 1.14× | 0.82× | ||
| Q1 25 | 1.08× | 0.82× | ||
| Q4 24 | 1.04× | 0.79× | ||
| Q3 24 | 1.00× | 0.78× | ||
| Q2 24 | 0.98× | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | — |
| 自由现金流经营现金流 - 资本支出 | $357.0M | — |
| 自由现金流率自由现金流/营收 | 49.6% | — |
| 资本支出强度资本支出/营收 | 124.4% | — |
| 现金转化率经营现金流/净利润 | 10.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $258.4M | ||
| Q3 25 | $315.0M | $139.4M | ||
| Q2 25 | $363.5M | $90.3M | ||
| Q1 25 | $279.4M | $-7.2M | ||
| Q4 24 | $1.1B | $36.1M | ||
| Q3 24 | $318.2M | $160.4M | ||
| Q2 24 | $316.2M | $195.7M |
自由现金流DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | — | ||
| Q3 25 | — | $130.2M | ||
| Q2 25 | — | $81.2M | ||
| Q1 25 | — | $-16.6M | ||
| Q4 24 | $333.7M | $25.8M | ||
| Q3 24 | — | $150.7M | ||
| Q2 24 | — | $185.9M |
自由现金流率DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | — | ||
| Q3 25 | — | 9.1% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | 47.8% | 2.0% | ||
| Q3 24 | — | 11.8% | ||
| Q2 24 | — | 15.1% |
资本支出强度DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | 124.4% | — | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | 105.6% | 0.8% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.8% |
现金转化率DOCOPCH
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | 4.42× | ||
| Q3 25 | — | 2.69× | ||
| Q2 25 | 11.48× | 1.79× | ||
| Q1 25 | 6.52× | -0.15× | ||
| Q4 24 | 235.43× | 0.60× | ||
| Q3 24 | 3.71× | 2.98× | ||
| Q2 24 | 2.17× | 3.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
